Fridays vs Hers
Hers has an open FDA warning letter dated September 9, 2025. Fridays has none. On compounded semaglutide injection, Hers costs $600 less a year at standing rates: $199 a month against $249 a month at Fridays.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Fridays / Hers
Fridays
5.8/10
Hers
6.8/10
- Red Rock Compounding Pharmacy503A
- Health Warehousetype not stated
- Precision Medicinetype not stated
- and 1 more
- Apostrophe Pharmacy LLCtype not stated
- XeCare LLCtype not stated
- MedisourceRx503B
Neither Fridays nor Hers pays us. Links to them earn nothing. Scores: Fridays 5.8, Hers 6.8. How we are paid
What the record shows
- 01
Hers has an open FDA warning letter dated September 9, 2025. Fridays has none.
- 02
Fridays names four pharmacies. Hers names three pharmacies.
- 03
On compounded semaglutide injection, Hers costs $600 less a year at standing rates: $199 a month against $249 a month at Fridays.
- 04
Only Fridays lists a price for compounded tirzepatide injection and brand-name semaglutide pen.
- 05
Hers lists all 50 states. Fridays publishes no state list.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Fridays
Hers
$249/mo
$2,988 a year
$199/moLower
$2,388 a year
$1,828/mo
$21,936 a year
$299/mo
medication only, membership extra; not compared
$359/mo
$4,308 a year
$1,498/mo
$17,976 a year
Read off each seller’s own pages. Fridays: October 30, 2026. Hers: September 28, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Fridays
5.8/10- No FDA warning letter on record
- Sells compounded tirzepatide injection and brand-name semaglutide pen, which Hers does not price
- Price includes clinician visits and coaching
- Publishes no state list
The case for Hers
6.8/10- $600 a year less on compounded semaglutide injection
- Open FDA warning letter, September 9, 2025
- Price leaves out clinician visits and coaching
Scores
Fridays 5.8 · Hers 6.8 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Fridays vs Hers: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- DudeMeds6.8
From $175/mo prepaid
Visit site - HumeCare+6.6
From $199/mo
Visit site - Collective9.1
From $59/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks